表3
拉唑不良事件在单剂和pantoprazole-based三重治疗。
|
| 不良事件 |
EAC集团(n= 208) |
PAC集团(n= 244) |
P价值 |
|
| 腹泻 |
7 (3.4%) |
10 (4.1%) |
.131 |
| 便秘 |
1 (0.5%) |
2 (0.8%) |
1.000 |
| 腹部疼痛 |
3 (1.4%) |
9 (3.7%) |
.241 |
| 厌食症 |
1 (0.5%) |
3 (1.2%) |
.633 |
| 恶心 |
7 (3.4%) |
8 (3.3%) |
1.000 |
| 呕吐 |
1 (0.5%) |
4 (1.6%) |
.388 |
| 皮疹 |
0 (0%) |
5 (2%) |
.069 |
| 头晕 |
12 (5.8%) |
11 (4.5%) |
.519 |
| 头痛 |
2 (1%) |
8 (3.3%) |
.196 |
| 品味曲解 |
32 (15.4%) |
29 (11.9%) |
.209 |
| 疲劳 |
10 (4.8%) |
6 (2.5%) |
.198 |
|
|
